Risk of Serious Upper Gastrointestinal Toxicity With Over-the-Counter Nonaspirin Nonsteroidal Anti-inflammatory Drugs

Lewis, 2002, Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s, Am J Gastroenterol, 97, 2540, 10.1111/j.1572-0241.2002.06037.x Hawkey, 2000, Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs, Gut, 46, 310, 10.1136/gut.46.3.310 Walsh, 1995, The treatment of Helicobacter pylori infection in the management of peptic ulcer disease, N Engl J Med, 333, 984, 10.1056/NEJM199510123331508 Singh, 1999, Epidemiology of NSAID induced gastrointestinal complications, J Rheumatol, 26, 18 Wolfe, 1999, Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs, N Engl J Med, 340, 1888, 10.1056/NEJM199906173402407 Gabriel, 1991, Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis, Ann Intern Med, 115, 787, 10.7326/0003-4819-115-10-787 Henry, 1996, Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs, BMJ, 312, 1563, 10.1136/bmj.312.7046.1563 Lewis, 2002, Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding, Br J Clin Pharmacol, 54, 320, 10.1046/j.1365-2125.2002.01636.x Langman, 1994, Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs, Lancet, 343, 1075, 10.1016/S0140-6736(94)90185-6 Henry, 1993, Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs, Gastroenterology, 105, 1078, 10.1016/0016-5085(93)90952-9 Bombardier, 2000, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group, N Engl J Med, 343, 1520, 10.1056/NEJM200011233432103 Hartge, 1984, Random digit dialing in selecting a population-based control group, Am J Epidemiol, 120, 825, 10.1093/oxfordjournals.aje.a113955 Harlow, 1983, Telephone household screening and interviewing, Am J Epidemiol, 117, 632, 10.1093/oxfordjournals.aje.a113586 Metlay, 2003, Agreement between patient self-report and a Veterans Affairs national pharmacy database for identifying recent exposures to antibiotics, Pharmacoepidemiol Drug Saf, 12, 9, 10.1002/pds.772 Klungel, 2000, Influence of question structure on the recall of self-reported drug use, J Clin Epidemiol, 53, 273, 10.1016/S0895-4356(99)00167-5 Kimmel, 2003, Enhancement of medication recall using medication pictures and lists in telephone interviews, Pharmacoepidemiol Drug Saf, 12, 1, 10.1002/pds.764 Strom, 2004, An interview strategy was critical for obtaining valid information on the use of hormone replacement therapy, J Clin Epidemiol, 57, 1210, 10.1016/j.jclinepi.2004.04.001 2003 Griffin, 1991, Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons, Ann Intern Med, 114, 257, 10.7326/0003-4819-114-4-257 Belsey, 1980 Mickey, 1989, The impact of confounder selection criteria on effect estimation, Am J Epidemiol, 129, 125, 10.1093/oxfordjournals.aje.a115101 Peduzzi, 1996, A simulation study of the number of events per variable in logistic regression analysis, J Clin Epidemiol, 49, 1373, 10.1016/S0895-4356(96)00236-3 de Abajo, 1999, Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding, BMJ, 319, 1106, 10.1136/bmj.319.7217.1106 Dalton, 2003, Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding, Arch Intern Med, 163, 59, 10.1001/archinte.163.1.59 Chan, 2005, Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding, N Engl J Med, 352, 238, 10.1056/NEJMoa042087 Ng, 2003, High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease, Aliment Pharmacol Ther, 18, 443, 10.1046/j.1365-2036.2003.01693.x Conn, 1976, Nonassociation of adrenocorticosteroid therapy and peptic ulcer, N Engl J Med, 294, 473, 10.1056/NEJM197602262940905 Lanas, 2000, Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding, N Engl J Med, 343, 834, 10.1056/NEJM200009213431202 Lewis, 2005, Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure Blot, 2000, Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding, J Epidemiol Biostat, 5, 137 Strom, 1997, Gastrointestinal tract bleeding associated with naproxen sodium vs ibuprofen, Arch Intern Med, 157, 2626, 10.1001/archinte.1997.00440430108013 Weil, 1995, Prophylactic aspirin and risk of peptic ulcer bleeding, BMJ, 310, 827, 10.1136/bmj.310.6983.827 Kelly, 1996, Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product, Lancet, 348, 1413, 10.1016/S0140-6736(96)01254-8 Wilcox, 1994, Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage, Arch Intern Med, 154, 42, 10.1001/archinte.1994.00420010064008 Kimmel, 2004, The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin, J Am Coll Cardiol, 43, 985, 10.1016/j.jacc.2003.08.064